Trademark: IMMUNOTHERAPY IN ONCOLOGY
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
IMMUNOTHERAPY IN ONCOLOGY
Click here to search for trademarks similar to IMMUNOTHERAPY IN ONCOLOGY
Proof of use for IMMUNOTHERAPY IN ONCOLOGY
We do not have any records of a proof of use for IMMUNOTHERAPY IN ONCOLOGY at this moment.
Click here to add a proof of use for IMMUNOTHERAPY IN ONCOLOGY
Possible trademark infringements of IMMUNOTHERAPY IN ONCOLOGY
Basic Information about IMMUNOTHERAPY IN ONCOLOGY
- Serial Number
- 97154897
- Filing Date
- 03 Dec 2021
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of IMMUNOTHERAPY IN ONCOLOGY on the blockchain with WikiTrademarks.io.
- First use of IMMUNOTHERAPY IN ONCOLOGY anywhere
- IMMUNOTHERAPY IN ONCOLOGY was first used on 31 May 2011 for the primary classification of goods and services, international, 016 (Paper goods and printed matter)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 016
- US Codes
- 002; 005; 022; 023; 029; 037; 038; 050
Who owns IMMUNOTHERAPY IN ONCOLOGY?
1. The Lynx Group, LLC Cranbury NJ
Correspondent
- Brian L. Petrequin, Esq.
- GREENBERG TRAURIG LLP
- 500 CAMPUS DRIVE, SUITE 400
- FLORHAM PARK,NJ 07932
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io